Prospective monitoring of immune signatures in newly diagnosed high risk multiple myeloma patients under treatment with Isatuximab, Carfilzomib, Lenalidomide and Dexamethasone (I-KRd): First results of the GMMG-CONCEPT trial

Saved in:
Bibliographic Details
Published inClinical lymphoma, myeloma and leukemia Vol. 19; no. 10; pp. e141 - e142
Main Authors Asemissen, Anne Marie, Autenrieth, Stella, Bieber, Kristin, Gouttefangeas, Cecile, Rammensee, Hans-Georg, Besemer, Britta, Mann, Christoph, Blau, Igor Wolfgang, Schieferdecker, Aneta, Bokemeyer, Carsten, Goldschmidt, Hartmut, Weisel, Katja
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.10.2019
Online AccessGet full text

Cover

More Information
ISSN:2152-2650
DOI:10.1016/j.clml.2019.09.236